Recent studies have stated that the Multi-billion global next-generation point-of-care diagnostic markets are poised to grow strong from USD twenty-three billion in 2017 to USD thirty-eight billion by 2022, at a CAGR of ten-percent. The largest sector of diagnostics forecasted is in the breast cancer segment, due to the high incidence rate of breast cancer triggering the need for early screening and diagnostic tools.
The world needed a platform which is very simple, easy-to-use, portable and cost-effective in nature which seeks to replace ELISA-based screening technology. As a result, POC Medical Systems developed a next-generation diagnostics technology, named, Pandora CDxTM.
The Global Marketing Head of POC Medical Systems, Aparna Venkatesh, says, ‘There is a dire need for convenient and low-cost early screening for breast cancer and other diseases that today are expensive, cumbersome or painful. Such revolutionary technologies by POC will bring a paramount difference to the quality of a woman’s life, her family and the community.’
Pandora CDxTM is a scalable and a flexible platform enabling new applications for various life-threatening diseases, where early screening will make a paramount difference in the quality of one’s life.
An Organization on a Mission to ‘Save Lives’
POC Medical Systems Inc. is the brainchild of Sanjeev Saxena, Chairman and CEO, and was incepted in the year 2013. The company is a technology startup with a disruptive platform called Pandora CDxTM. This startup was instituted with a vision of ‘saving lives’ across the globe.
“Our sole intent to bring up this company was to address the dire need for creating medical diagnostics technology platform for screening cancer, cardiac and infectious diseases. Which is reliable, portable and accessible to every person living, even in the remotest corners of the world, at a very low cost,” says the founder.
The dream to create such state-of-the-art technology ultimately manifested in the form of Pandora CDxTM, which is creating a stir in the global diagnostics industry today.
Rapid Point-of-Care Screening Solutions
Pandora CDx- The Robust Miniature Lab
The recent epidemics like Ebola, Influenza, H7N9 virus, etc., in different parts of the world, have accentuated the early and accurate diagnosis by point-of-care screening facilities. This screening leads to the effective prevention and clinical management of infectious diseases.
Rapid diagnosis benefits patients in allowing timely therapy to prevent complications; and benefits public health. Collection of these data for epidemiological studies can prevent outbreaks and spread of diseases in future. However, the existing lab process in cumbersome in nature, which consists of collecting the blood sample, blood separation, mixing, incubation and determining the result by lab technicians.
Pandora CDx completely transformed the blood separation, mixing, incubation into the fully automated process, where blood is drawn from the finger and introduced into the sample port; microfluidics and centrifugal force replace the work done in the lab by technicians.
Simplifying Breast Cancer Screening
Millions of women lie undetected from the deadly cancer cells in the very first stage, due to the cumbersome and time-consuming screening procedure. And if detected, they have already reached its second or final stage. This screening facility is accessible mostly in the urban and semi-urban areas, leaving the rural population unreachable. Recovery from the second or final stage cancer is very a painful process and that too, it has its own implications, with least survival rate.
The standard Mammography process to detect breast cancer involves, disrobing the patient, compression, imagining, and an interpretation of test results, which is apparently can be repetitive and prolonged.
To overcome this impediment, POC Medical System’s indigenously developed Pandora CDx, has an incredible breast cancer-screening tool called MammoAlertTM. It enables the early detection of breast cancer with a single drop of blood.
The tool system has been designed to provide a cost-effective, reliable test to enable population screening in developing countries like India and bring about 100% survival rates for Stage 1 breast cancer in developed countries. Any woman over the age of 30 can be screened safely and periodically using this minimally invasive test.
The Prolific Leader
The former President of United States, Dwight.D.Eisenhower once said, “The supreme quality of leadership is unquestionably integrity. Without it, no real success is possible, no matter whether it is on a section gang, a football field, in an army, or in an office.”
Sanjeev is spearheading POC Medical Systems with the utmost integrity and nurtured it into one of the top next-generation diagnostics company over the years. He is an internationally acclaimed serial entrepreneur and cofounded several Biotech and Medical device companies in the past.
A true leader’s thoughts reflect through his positive actions which results into a constructive society.
Awards and Accolades
Abraham Lincoln once said, “Don’t worry when you are not recognized, but strive to be worthy of recognition.”
Sanjeev is a multifaceted personality, who has bagged several awards and recognition for his outstanding work. He is honored with the prestigious ‘Udhog Lagu’ award in India and ‘The European Science’ award in the UK.
He was also nominated by Ernst and Young for the ‘Entrepreneur of the Year’ award in 2011 in India. POC has been profiled in Inc, Entrepreneur and was felicitated by the CSR World Congress with the ‘50 most Social Innovator’ awards.
The company has achieved the feat of time and again awarded the ‘Risk Takers and Dreamers’ award and the ‘Game Changer’ award by the Tri-Valley Innovation.
Pandora CDx is a platform technology that will allow for other screening panels to be ported on. We will continue to develop more screening panels that are affordable in oncology, cardiac and infectious diseases, expressed the founder.
Ramana Tadepalli, COO, asserts that ‘We truly believe our solution will be the most affordable accessible and low-cost screening option that can help save lives.’ This disruptive technology platform is targeted to provide point-of-care screening rapidly, efficiently and effortlessly using a minimally invasive and safe technique.
The screening tool will enable ‘distributed but connected point-of-care’ screening and diagnostics to bring a paradigm shift in the way breast cancer will be treated in the world.